Pravdina N F, Shobukhov V M, Veselovska T V, Smirnova N R, Galegov G A
Vopr Med Khim. 1979 Mar-Apr;25(2):193-8.
Methotrexate was shown to inhibit development of Rausher's leukosis and growth of spleen. Activity of DNA-dependent RNA polymerases A and B was distinctly altered. The activity of RNA polymerase B was increased two-fold within the first days of the leukosis development; RNA polymerase A was activated five-fold in the course of subsequent progression of the impairment. Methotrexate inhibited the RNA polymerase activity in leukemic spleens. As suggested by correlation between weight of the spleen and the activity of RNA polymerases A and B, the enzymatic activity may be considered as a marker of the leukosis development.
已证明甲氨蝶呤可抑制劳舍尔白血病的发展及脾脏生长。DNA依赖性RNA聚合酶A和B的活性发生了明显改变。在白血病发展的最初几天内,RNA聚合酶B的活性增加了两倍;在损伤随后的进展过程中,RNA聚合酶A被激活了五倍。甲氨蝶呤抑制白血病脾脏中的RNA聚合酶活性。根据脾脏重量与RNA聚合酶A和B活性之间的相关性推测,酶活性可被视为白血病发展的一个标志物。